Skip to main content
. Author manuscript; available in PMC: 2011 Jul 19.
Published in final edited form as: J Invest Dermatol. 2010 Sep 2;131(1):84–98. doi: 10.1038/jid.2010.253

Table 1.

KDs for PDGF-BB interactions with FN domains derived from ka and kd

PDGF-BB
ka (m−1 s−1)
PDGF-BB
kd (s−1)
PDGF-BB
KD (nm)1
EGF
KD (nm)
FN70 NBB2 NBB NBB NBB
rFNIII1–113 3.0 × 105 2.8 × 10−2 93 NBB
rFNIII1–7 5.1 × 105 4.2 × 10−2 82 NBB
rFNIII1–2 7.6 × 105 8.2 × 10−2 108 NBB
rFNIII1 3.5 × 105 3.6 × 10−2 103 NBB
FNIII2–114
(FN120)
NBB NBB NBB NBB
rFNIII3–6 NBB NBB NBB NBB
rFNIII8–11 NBB NBB NBB NBB
rFNIII 12–V155 8.0 × 105 2.3 × 10−2 29 NBB
rFNIII12–15 4.5 × 105 1.2 × 10−2 27 NBB
rFNIII12–14 5.6 × 105 2.7 × 10−2 48 NBB
rFNIII13–14 4.5 × 104 4.1 × 10−4 9 NBB
rV5 2.9 × 105 4.1 × 10−2 141 NBB

Abbreviations: FN, fibronectin; rFNIII, recombinant fibronectin type III repeat; ka, kinetic association constant; kd, kinetic dissociation constant; KD, dissociation constant; PDGF-BB, platelet-derived growth factor-BB

1

KD (nm) derived from surface plasmon resonance determinations.

2

NBB, no binding observed as determined by surface plasmon resonance determinations.

3

rFNIII, recombinant FN domain produced as previously described (Wang et al., 2005).

4

FNIII2–11 by QStar pulsar I quadrupole time-of-flight mass spectroscopy sequence identification of FN120 fragment.

5

rFNIII12–V15, recombinant FN domain in which the variable domain (V) contains 120 residues.

PDGF-BB binding for FN and rFNIII8–V15 could not be determined secondary to high noise.